April 2016
ONS Get Up, Get Moving Champions
The evidence is strong! Physical activity is an effective intervention to combat cancer related fatigue and may help mitigate treatment related symptoms such as anxiety and depression, lymphedema and sleep quality – not to mention improve bone and muscle strength. A number of observational studies demonstrate the therapeutic benefit of physical activity during and after cancer treatment with a reduction in cancer recurrence of between 10-50% in a number of cancer types for patients who engaged in regular physical activity during and after cancer treatment.
National Cancer Moonshot Initiative Could Learn From Open-Source Data Ideas
- Read more about National Cancer Moonshot Initiative Could Learn From Open-Source Data Ideas
- Add new comment
Patrick Flynn
FDA Approves Defibrotide Sodium for Hepatic Veno-Occlusive Disease
On March 30, 2016, the U.S. Food and Drug Administration approved Defitelio® (defibrotide sodium, Jazz Pharmaceuticals, Inc.) for the treatment of adult and pediatric patients with hepatic veno-occlusive disease, also known as sinusoidal obstructive syndrome, with renal or pulmonary dysfunction following hematopoietic stem cell transplantation.
ASCO Annual Meeting
The American Society of Clinical Oncology (ASCO) Annual Meeting brings together 30,000 oncology professionals from around the world. The theme of the 2016 meeting is Collective Wisdom: The Future of Patient-Centered Care and Research, with a focus on shaping the future of patient care and research through a collaborative approach among healthcare providers.
ONS will be reporting live from the conference in June.